Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
4.210
-0.200 (-4.54%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Tevogen Bio Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.69 | 0.55 | 1.28 | 1.05 | 0.13 | 0.34 |
Short-Term Investments | - | - | - | - | 356.86 | 351.92 |
Cash & Short-Term Investments | 0.69 | 0.55 | 1.28 | 1.05 | 356.99 | 352.26 |
Cash Growth | -64.94% | -56.95% | 21.91% | -99.70% | 1.34% | - |
Other Receivables | 0.16 | 0.16 | 0.16 | - | - | - |
Total Trade Receivables | 0.16 | 0.16 | 0.16 | - | - | - |
Other Current Assets | 1.29 | 0.83 | 0.92 | 0.67 | 0.15 | 0.45 |
Total Current Assets | 2.14 | 1.54 | 2.36 | 1.72 | 0.27 | 0.79 |
Net Property, Plant & Equipment | 1.53 | 1.59 | 0.52 | 0.93 | - | - |
Other Long-Term Assets | 1.25 | 1.25 | 0.58 | 2.85 | - | 0.15 |
Total Assets | 4.92 | 4.38 | 3.46 | 5.51 | 357.14 | 352.85 |
Accounts Payable | 3.8 | 3.34 | 5.2 | 3.42 | 0.21 | 0.04 |
Accrued Expenses | 1.24 | 1.5 | 1.71 | 1.1 | - | - |
Short-Term Debt | 1.65 | 1.65 | 1.65 | 80.71 | - | - |
Current Portion of Leases | 0.33 | 0.33 | 0.23 | 0.25 | - | - |
Other Current Liabilities | 0.25 | 0.25 | 0.25 | - | 0.14 | 0.02 |
Total Current Liabilities | 7.27 | 7.07 | 9.04 | 85.48 | 0.35 | 0.06 |
Long-Term Debt | 6.4 | 4.4 | 1 | 14.22 | - | - |
Long-Term Leases | 1.09 | 1.12 | 0.01 | 0.23 | - | - |
Other Long-Term Liabilities | 0 | 0.03 | 0.09 | - | 14.71 | 15.12 |
Total Long-Term Liabilities | 7.49 | 5.55 | 1.09 | 14.45 | 14.71 | 15.12 |
Total Liabilities | 14.76 | 12.62 | 10.14 | 99.93 | 15.06 | 15.18 |
Preferred Stock | 8.8 | 8.8 | 8.8 | - | - | - |
Common Stock | 0 | 0 | 0 | 0.01 | 0 | 0 |
Additional Paid-in Capital | 126.46 | 122.63 | 97.91 | 5.22 | - | - |
Retained Earnings | -145.11 | -139.66 | -113.39 | -99.66 | -14.78 | -14.23 |
Total Common Shareholders' Equity | -9.84 | -8.23 | -6.67 | -94.43 | -14.78 | -14.23 |
Minority Interest | - | - | - | - | 356.86 | 351.9 |
Shareholders' Equity | -9.84 | -8.23 | -6.67 | -94.43 | 342.08 | 337.67 |
Total Liabilities & Equity | 4.92 | 4.38 | 3.46 | 5.51 | 357.14 | 352.85 |
Total Debt | 9.47 | 7.5 | 2.89 | 95.42 | 0 | 0 |
Net Cash (Debt) | -8.78 | -6.95 | -1.6 | -94.37 | 356.99 | 352.26 |
Net Cash Growth | - | - | - | - | 1.34% | - |
Net Cash Per Share | -2.67 | -2.09 | -0.55 | -190.63 | 706.82 | 2446.66 |
Book Value | -9.84 | -8.23 | -6.67 | -94.43 | -14.78 | -14.23 |
Book Value Per Share | -2.99 | -2.48 | -2.28 | -190.75 | -29.27 | -98.82 |
Tangible Book Value | -9.84 | -8.23 | -6.67 | -94.43 | -14.78 | -14.23 |
Tangible Book Value Per Share | -2.99 | -2.48 | -2.28 | -190.75 | -29.27 | -98.82 |